KarXT (Cobenfy) is the first antipsychotic that doesn’t block dopamine. We trace the origins of this new drug to a south Asian herb used for over 5,000 years, up to the three EMERGENT trials that lead to its FDA approval.

CME: Take the CME Post-Test for this Episode

Published On: 10/07/2024

Duration: 12 minutes, 28 seconds

Chris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.